154P Results of an open-label, phase Ia/Ib study of olaratumab plus pembrolizumab in patients with unresectable, locally advanced or metastatic soft tissue sarcoma

Autor:	P. Schöffski, R. Bahleda, A.J. Wagner, M. Burgess, N. Junker, M. Chisamore, P. Peterson, M. Ceccarelli, T. William
Rok vydání:	2021
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 32:S1447
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.10.173
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a8c9e5ae9684321e4494596522644694 https://doi.org/10.1016/j.annonc.2021.10.173 Zobrazit plný text záznamu